U.S Disposable Syringes Market Size to Surpass USD 6.62 Bn by 2032
The U.S Disposable Syringes market size was estimated at USD 3.90 billion in 2022 and is expected to surpass around USD 6.62 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 5.44% during the forecast period 2023 to 2032.
Key Takeaways:
U.S Disposable Syringes Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 4.11 Billion |
| Market Size by 2032 | USD 6.62 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 5.44% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product, Application, End-use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Cardinal Health; B. Braun Melsungen; Terumo Corporation; ICU Medical, Inc. (Smiths Medical) Nipro Corporation, BD; Sol-Millennium Medical; CODAN Medizinische Geräte GmbH & Co KG; Cole-Parmer Instrument Company, LLC; Henke-Sass, Wolf, UltiMed, Inc. |
The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S disposable syringes.
The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S disposable syringes market.
Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.
Product Insights
The safety syringes led the market and accounted for more than 63.55% share of the U.S revenue in 2022. The safety syringes are majorly used for administering medications by utilizing specialized and standard techniques. The unsafe injection practices lead to almost 33,800 HIV infections, 315,000 hepatitis C transmissions, and 1.7 million hepatitis B infections every year globally. Unsafe practices such as multiple use of a syringe & needle without taking precautionary measures as guided by the healthcare professionals lead to needlestick injuries. In addition, conventional disposable syringes provide protection to the recipient, but do not assure the safety of patients. Such factors are anticipated to boost the segment growth.
The WHO has issued guidelines for the use of safety syringes to prevent needlestick injuries. The aim of these guidelines is to prevent the reuse of conventional syringes. The International Organization for Standardization (ISO) has also issued a set of requirements for manufacturers of safety syringes to ensure safety and high performance level of the products.
The conventional syringes are the second leading segment in 2022. Conventional syringes are mostly made of plastic with visible graduation and are intended for single use. Some of the advantages of disposable conventional syringes are that they eliminate the risk of infections from blood-borne pathogens, such as HIV, Ebola virus, and Hepatitis B & C. However, less use of disposable conventional syringes & needles in undeveloped countries due to high additional costs for maintenance may hamper the segment growth. The governments in these countries are undertaking initiatives to increase the use of conventional disposable syringes & needles with an aim to reduce the transmission of diseases in patients; thereby, propelling the segment growth over the forecast period.
Application Insights
The therapeutic injections led the market and accounted for more than 85.79% share of the U.S revenue in 2022. Increasing awareness toward blood donations in the country is one of the major factors for driving the segment. For instance, as per the America’s Blood Centers, approximately 3 percent of the U.S. population donates blood each year. There were approximately 7.3 million donors in 2019. High prevalence of diseases such as AIDS, tuberculosis, malaria, and dengue leads to demand for high volume of injections as they are one of the essential requirements for diagnosis and treatment.
Furthermore, developments in drugs and delivery systems is also expected to propel the segment growth. For instance, in 2022, CytoDyn, Inc. has completed phase 3 clinical trial of their injectable HIV drug. This injectable is expected to replace the daily antiretroviral pill dose with once-a-week injection, thus improving the quality of life of the 33.00 million people living with AIDS. The success of this drug is expected to provide great opportunity for the growth of disposable syringes market over the forecast period.
The immunization injections segment is anticipated to witness the fastest growth over the forecast period. The process of vaccination is majorly a mass activity, thus, increasing the risk of transmission of blood-borne pathogens. In such cases, the multiple use of a syringe & needle needs to be avoided to prevent the risk of needlestick injuries. In addition, the type of injections used depends on the safety, cost, and type of vaccine to be administered. Prefilled auto-disable syringes are majorly preferred, provided all the vaccines are available in a prefilled form. This prevents vaccine contamination, increases the accuracy of dose, and reduces the waste generated due to multiple vials.
End-use Insights
The hospitals led the market and accounted for more than 34.95% share of the U.S revenue in 2022. Hospital institutions are the largest market for disposable syringes as they cater to majority of the population at any given time. In terms of volume of disposable syringes, hospitals are observed to be the largest consumer of related products and services. Furthermore, hospitals are considered significant buyers because they have long-term contracts with providers of disposable syringes, which gives them higher negotiation leverage and makes them a larger market for product after-sales services. Furthermore, the increasing rate of hospitalization due to rise in trauma cases, & other infectious diseases; growing number of well-furnished, well-equipped, & advanced hospitals; aging population; and increasing prevalence of chronic diseases are expected to drive the segment growth
The other segment is anticipated to witness the fastest growth over the forecast period. The others section includes academic & medical research centers, ambulatory surgical centers, and defense forces. Increasing healthcare expenditure can boost the number of research centers and academics, owing to which, this segment is anticipated to witness growth over the forecast period. The need for optimum sterility and accuracy in research procedures has resulted in increased demand for sterile disposable syringes in academic and medical research centers. Sterility is of utmost importance in research centers, owing to increasing awareness about possible contamination and increase in academic & research centers. Furthermore, the FDA and other regulatory bodies has set guidelines to review the safety and sterility practices in research labs, which is expected to boost segment growth.
States Insights
Texas dominated the market and accounted for over 8.32% share of U.S revenue in 2022. This is due to the fact that there are many uninsured adults in these states, a high rate of preventable deaths, lack of investment in public health, a large number of people with mental illness who cannot access care, and rising insurance costs that make healthcare more expensive than in many other regions of the country.
In addition, Texas saw the most increase in population—4 million—of any state over the preceding 10 years. Due to difficulties for residents of the state to access and afford the healthcare services. Texas ranked 42nd overall on assessment of the functioning of the healthcare system. Its residents are less likely to report having a regular source of healthcare, which is a crucial indicator of how effectively the healthcare system is performing. It also has the highest number of uninsured people in the nation.
Texas citizens are most likely to report forgoing needed medical care due to cost, while the state's residents pay a larger proportion of their incomes toward health insurance than residents of nearly every other state. In addition, Texas is one of the 14 states that have not yet expanded Medicaid in accordance with ACA rules, leaving millions of working people without insurance.
California disposable syringes market is anticipated to witness the fastest growth over the forecast. In California, approximately 700 hospitalizations per 100,000 people were possibly preventable through effective chronic care management and access to high-quality primary care, based on a composite measure of hospital admission rates for 8 chronic care conditions. The preventable hospitalization rate varied from high of 1,341 in Butte County. to a low of 129 in Mono County.
U.S Disposable Syringes Market Share Insights
Companies that sell U.S disposable syringes are stepping up their efforts to get their products approved so that manufacturers can start mass production. One of the main areas of concern for manufacturers is the avoidance of unintentional needle stick injuries in healthcare settings.
In addition, the market players are adopting various strategies, such as mergers & acquisitions, partnership, product launches and innovations products to strengthen their foothold in the market. For instance, in January 2022 Smith's Medical collaborates with the U.S government to develop a COVID-19 vaccine. In order to support the Operation Warp Speed immunization programme, the cooperation with BARDA and JPEO-CBRND comprises a USD 20 million investment for enhanced syringe and needle device production, which is expected to enhance market growth in the near future. Some prominent players in the U.S disposable syringes market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S Disposable Syringes market.
By Product
By Application
By End-use
By States
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers